178 related articles for article (PubMed ID: 23891099)
41. The threshold of hypothyroidism after radiation therapy for head and neck cancer: a retrospective analysis of 116 cases.
Fujiwara M; Kamikonya N; Odawara S; Suzuki H; Niwa Y; Takada Y; Doi H; Terada T; Uwa N; Sagawa K; Hirota S
J Radiat Res; 2015 May; 56(3):577-82. PubMed ID: 25818629
[TBL] [Abstract][Full Text] [Related]
42. V30 as a predictor for radiation-induced hypothyroidism: a dosimetric analysis in patients who received radiotherapy to the neck.
Akgun Z; Atasoy BM; Ozen Z; Yavuz D; Gulluoglu B; Sengoz M; Abacioglu U
Radiat Oncol; 2014 May; 9():104. PubMed ID: 24885512
[TBL] [Abstract][Full Text] [Related]
43. External validation of a multifactorial normal tissue complication probability model for tube feeding dependence at 6 months after definitive radiotherapy for head and neck cancer.
Kanayama N; Kierkels RGJ; van der Schaaf A; Steenbakkers RJHM; Yoshioka Y; Nishiyama K; Fujii T; Ogawa K; Langendijk JA; Teshima T
Radiother Oncol; 2018 Nov; 129(2):403-408. PubMed ID: 30301559
[TBL] [Abstract][Full Text] [Related]
44. Incidence of hypothyroidism following multimodality treatment for advanced squamous cell cancer of the head and neck.
Posner MR; Ervin TJ; Miller D; Fabian RL; Norris CM; Weichselbaum RR; Rose C
Laryngoscope; 1984 Apr; 94(4):451-54. PubMed ID: 6708688
[TBL] [Abstract][Full Text] [Related]
45. Thyroid diseases as a sequelae following treatment of head and neck cancer.
Banipal R; Mahajan MK; Uppal B; John M
Indian J Cancer; 2011; 48(2):194-8. PubMed ID: 21768665
[TBL] [Abstract][Full Text] [Related]
46. Factors predictive of the development of hypothyroidism after intensity-modulated radiation therapy for pharyngeal cancer.
Inoue E; Okajima K; Doi H; Fukuda K; Oguma Y; Ri A; Nishikawa D; Yane K; Matsuura T; Nishimura Y
Acta Otolaryngol; 2021 Nov; 141(11):1022-1026. PubMed ID: 34738883
[TBL] [Abstract][Full Text] [Related]
47. Radiation-induced hypothyroidism in patients of oral squamous cell carcinoma: A retrospective analysis of 195 patients.
Jain PV; Das A; Manikantan K; Sharan R; Mallick I; Chatterjee S; Arun P
Indian J Cancer; 2022; 59(4):480-484. PubMed ID: 33753621
[TBL] [Abstract][Full Text] [Related]
48. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
[TBL] [Abstract][Full Text] [Related]
49. The impact of nutritional counseling on thyroid disorders in head and neck cancer patients after (chemo)radiotherapy: results from a prospective interventional trial.
Löser A; Ramke K; Grohmann M; Krause L; Roser P; Greinert F; Finger A; Sommer M; Culmann E; Lorenz T; Becker S; Henze M; Schodrok D; von Grundherr J; Tribius S; Krüll A; Petersen C
Strahlenther Onkol; 2022 Feb; 198(2):135-148. PubMed ID: 34724084
[TBL] [Abstract][Full Text] [Related]
50. Identification of Patient Benefit From Proton Therapy for Advanced Head and Neck Cancer Patients Based on Individual and Subgroup Normal Tissue Complication Probability Analysis.
Jakobi A; Bandurska-Luque A; Stützer K; Haase R; Löck S; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1165-1174. PubMed ID: 26194685
[TBL] [Abstract][Full Text] [Related]
51. Computed Tomography Density Change in the Thyroid Gland Before and After Radiation Therapy.
Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Okada M; Matsushita J
Anticancer Res; 2018 Jan; 38(1):417-421. PubMed ID: 29277803
[TBL] [Abstract][Full Text] [Related]
52. [Secondary hypothyroidism after cervical irradiation: systematic evaluation of thyroid function in follow-up].
Gonçalves SM; Ferreira BC; Guardado MJ; Marques R; Serra T; Serra MJ; Roda D; Brandão J; Melo G; Lopes MC; Khouri L
Acta Med Port; 2014; 27(4):467-72. PubMed ID: 25203955
[TBL] [Abstract][Full Text] [Related]
53. Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer.
Tell R; Lundell G; Nilsson B; Sjödin H; Lewin F; Lewensohn R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):395-400. PubMed ID: 15380571
[TBL] [Abstract][Full Text] [Related]
54. Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study.
Deneuve S; Bastogne T; Duclos M; Mirjolet C; Bois P; Bachmann P; Nokovitch L; Roux PE; Girodet D; Poupart M; Zrounba P; Claude L; Ferella L; Iacovelli NA; Foray N; Rancati T; Pereira S
Tumori; 2023 Apr; 109(2):173-185. PubMed ID: 35578746
[TBL] [Abstract][Full Text] [Related]
55. Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy.
Lee TF; Yeh SA; Chao PJ; Chang L; Chiu CL; Ting HM; Wang HY; Huang YJ
Radiat Oncol; 2015 Sep; 10():194. PubMed ID: 26377924
[TBL] [Abstract][Full Text] [Related]
56. Individualized Prophylactic Neck Irradiation in Patients with cN0 Head and Neck Cancer Based on Sentinel Lymph Node(s) Identification: Definitive Results of a Prospective Phase 1-2 Study.
Longton E; Lawson G; Bihin B; Mathieu I; Hanin FX; Deheneffe S; Vander Borght T; Laloux M; Daisne JF
Int J Radiat Oncol Biol Phys; 2020 Jul; 107(4):652-661. PubMed ID: 32294522
[TBL] [Abstract][Full Text] [Related]
57. Thyroid disorders in patients treated with radiotherapy for head-and-neck cancer: a retrospective analysis of seventy-three patients.
Alterio D; Jereczek-Fossa BA; Franchi B; D'Onofrio A; Piazzi V; Rondi E; Ciocca M; Gibelli B; Grosso E; Tradati N; Mariani L; Boboc GI; Orecchia R
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):144-50. PubMed ID: 17084554
[TBL] [Abstract][Full Text] [Related]
58. Lumbosacral spine and marrow cavity modeling of acute hematologic toxicity in patients treated with intensity modulated radiation therapy for squamous cell carcinoma of the anal canal.
Cheng JC; Bazan JG; Wu JK; Koong AC; Chang DT
Pract Radiat Oncol; 2014; 4(3):198-206. PubMed ID: 24766688
[TBL] [Abstract][Full Text] [Related]
59. Thyroid dysfunction after intra-arterial chemotherapy for hypopharyngeal and laryngeal cancer.
Endo K; Masatani T; Tsuji A; Kondo S; Wakisaka N; Murono S; Yoshizaki T
Auris Nasus Larynx; 2015 Jun; 42(3):231-4. PubMed ID: 25544714
[TBL] [Abstract][Full Text] [Related]
60. A multivariable normal tissue complication probability model for predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma patients in the modern radiotherapy era.
Wongwattananard S; Prayongrat A; Srimaneekarn N; Hayter A; Sophonphan J; Kiatsupaibul S; Veerabulyarith P; Rakvongthai Y; Ritlumlert N; Kitpanit S; Kannarunimit D; Lertbutsayanukul C; Chakkabat C
J Radiat Res; 2024 Jan; 65(1):119-126. PubMed ID: 37996086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
